ArticleMicroorganisms2020
Spread of ST348
Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 22 citations in OpenAlex.
- Expanding Threat of Carbapenemase-ProducingbioRxiv : the preprint server for biology · 2026Article
- Expression of Concern: Pons et al. Spread of ST348Microorganisms · 2025Article
- Traditional marketed meats as a reservoir of multidrug-resistant Escherichia coli.International microbiology : the official journal of the Spanish Society for Microbiology · 2025Article
- Identification of pandemic ST147, ESBL-type β-lactamases, carbapenemases, and virulence factors in Klebsiella pneumoniae isolated from southern Peru.Scientific reports · 2025Article
- Emerging carbapenem-resistantMicrobiology spectrum · 2025Article
- Antimicrobial resistance and associated risk factors inVeterinary world · 2024Article
- Molecular characterization of carbapenemase-producing Enterobacterales in a tertiary hospital in Lima, Peru.Microbiology spectrum · 2024Article
- Super-infection by multiple microorganisms in COVID-19 patients.Frontiers in molecular biosciences · 2023Article
- Antibiotic susceptibility among non-clinicalHeliyon · 2022Review
- Peru - Progress in health and sciences in 200 years of independence.Lancet regional health. Americas · 2022Review
- Fungal, parasitological, and bacterial coinfection in a severely ill COVID-19 patient in Peru.Clinical case reports · 2022Article
- A case-control study of infections caused byFrontiers in cellular and infection microbiology · 2022Article
- Genome Sequencing Identifies Previously Unrecognized Klebsiella pneumoniae Outbreaks in Neonatal Intensive Care Units in the Philippines.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021Article
- In Vitro and In Vivo Evaluations of β-Lactam/β-Lactamase Mono- and Combined Therapies against Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan.Microorganisms · 2020Article
Corrections and comments
- Expression of concern
Authors and funding
9 authors at 4 institutions in 2 countries.
Funding
Abstract
The aim of this study was to characterize carbapenem-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.